DECIBEL THERAPEUTICS INC's ticker is DBTX and the CUSIP is 24343R106. A total of 40 filers reported holding DECIBEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $444,932 | +27.5% | 115,567 | 0.0% | 0.00% | – |
| Q1 2023 | $349,012 | +147786.4% | 115,567 | 0.0% | 0.00% | – |
| Q4 2022 | $236 | -99.9% | 115,567 | +3.7% | 0.00% | – |
| Q3 2022 | $385,000 | +29.2% | 111,397 | +57.3% | 0.00% | – |
| Q2 2022 | $298,000 | +41.9% | 70,803 | +2.2% | 0.00% | – |
| Q1 2022 | $210,000 | -34.8% | 69,283 | 0.0% | 0.00% | – |
| Q4 2021 | $322,000 | -39.9% | 69,283 | -0.4% | 0.00% | – |
| Q3 2021 | $536,000 | -13.1% | 69,556 | -3.2% | 0.00% | – |
| Q2 2021 | $617,000 | -50.6% | 71,848 | -34.7% | 0.00% | – |
| Q1 2021 | $1,248,000 | – | 109,944 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATLAS CAPITAL ADVISORS LLC | 40,000 | $36,400 | 0.01% |